Cartalax 20 mg research-grade lyophilized peptide powder in a glass vial. Cartalax is a synthetic tetrapeptide bioregulator with the sequence Ala-Glu-Asp-Gly (AEDG), structurally related to Epithalon and studied in experimental models of musculoskeletal tissue, telomerase activity and gene-expression regulation.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
99%+ (HPLC, third-party tested)
Form
Lyophilized peptide powder
Content
20 mg Cartalax per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C (desiccated, protect from light)
Molecular formula
C14 H22 N4 O9
Molecular weight
~390.35 g·mol⁻¹
Sequence
Ala-Glu-Asp-Gly (AEDG)
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see
Bacteriostatic water – 10 ml .
Research Overview
Cartalax (AEDG tetrapeptide) is used in experimental bioregulator research to investigate musculoskeletal tissue homeostasis, telomerase-related mechanisms and gene-expression profiles in cartilage and bone cells. Studies focus on how short regulatory peptides may influence cellular proliferation, differentiation and stress responses in vitro and in vivo laboratory models, without implying any therapeutic application.
Primary Research Areas
-
Cartilage & bone tissue models: Musculoskeletal research exploring extracellular matrix turnover, chondrocyte and osteoblast activity, and structural maintenance of cartilage and bone tissue.
-
Telomerase & cellular aging: Experimental systems examining how AEDG-class peptides affect telomerase-associated pathways, cellular senescence markers and longevity-related signaling.
-
Gene-expression regulation: In vitro models investigating modulation of gene-expression networks in musculoskeletal and related cell types under various stress and adaptation conditions.
